Effect of GnRH-II on the ESC proliferation, apoptosis and VEGF secretion in patients with endometriosis in vitro

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 11, 2013, Pages 2487-2496

  Huang, Fengying ^a   Wang, Huanping ^b   Zou, Ying ^c   Liu, Qiuhong ^d   Cao, Jing ^a   Yin, Tuanfang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c Department of Comprehensive Treatment   (China)

^d People's Hospital of Hunan Province   (China)

Author keywords

Cell apoptosis; Cell proliferation; Endometrial stromal cells (ESC); Endometriosis (EMs); Gonadotropin releasing hormone II (GnRH II); In vitro; Vascular endothelial growth factor (VEGF)

Indexed keywords

DRUG DERIVATIVE; GONADORELIN; LHRH, HIS(5) TRP(7) TYR(8); LHRH, HIS(5)-TRP(7)-TYR(8)-; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; APOPTOSIS; ARTICLE; CASE CONTROL STUDY; CELL APOPTOSIS; CELL CULTURE; CELL PROLIFERATION; CELL SHAPE; DOSE RESPONSE; DRUG EFFECT; ENDOMETRIAL STROMAL CELLS (ESC); ENDOMETRIOSIS; ENDOMETRIOSIS (EMS); ENDOMETRIUM; FEMALE; GONADOTROPIN RELEASING HORMONE-II (GNRH-II); HUMAN; IN VITRO STUDY; METABOLISM; PATHOLOGY; SECRETION (PROCESS); STROMA CELL; TIME; VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF);

CELL APOPTOSIS; CELL PROLIFERATION; ENDOMETRIAL STROMAL CELLS (ESC); ENDOMETRIOSIS (EMS); GONADOTROPIN RELEASING HORMONE-II (GNRH-II); IN VITRO; VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF);

ADULT; APOPTOSIS; CASE-CONTROL STUDIES; CELL PROLIFERATION; CELL SHAPE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; STROMAL CELLS; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84887120121     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Hey-Cunningham AJ, Peters KM, Barrera-Villa Zevallos H, Berbic M, Markham R, Fraser IS. Angiogenesis, lymphangiogenesis and neurogenesis in endometriosis. Front Biosci (Elite Ed) 2013;1:1033-1056.
2. Polak G, Wertel I, Kwasniewski W, Derewianka-Polak M, Kotarski J. The role of iro metabolism and oxidative stress in the pathogenesis of endometriosis. Ginekol Pol 2013;84:62-64.
3. Paka C, Miller J, Nezhat C. Predictive factors and treatment of recurrence of endometriosis. Minerva Ginecol 2013;65:105-111.
4. Taylor RN, Hummelshoj L, Stratton P, Vercellini P. Pain and endometriosis:Etiology, impact, and therapeutics. Middle East Fertil Soc J 2012;17:221-225.
5. Sheaves C. Advances in endometriosis treatment. Nurse Pract 2013;38:42-47.
6. Tsutsumi M, Zhou W, Millar RP, Mellon PL, Roberts JL, Flanagan CA, Dong K, Gillo B, Sealfon SC. Cloning and functional expression of a mouse gonadotropin-releasing hormone receptor. Mol Endocrinol 1992;6:1163-1169.
7. Schrager S, Falleroni J, Edgoose J. Evaluation and treatment of endometriosis. Am Fam Physician 2013;87:107-113.
8. Ge CX, Zhu XH, Tang XQ. Efficacy of conservative laparoscopic surgery combined with Goserelin in treatment of 206 patients with severe ovarian endometriosis at short-term and long-term follow-up. Zhonghua Fu Chan Ke Za Zhi 2012 Aug;47:603-7.
9. Grigoriadis C, Papaconstantinou E, Mellou A, Hassiakos D, Liapis A, Kondi-Pafiti A. Clinicopathological changes of uterine leiomyomas after GnRH agonist therapy. Clin Exp Obstet Gynecol 2012;39:191-194.
10. Demeestere I, Brice P, Peccatori FA, Kentos A, Gaillard I, Zachee P, Casasnovas RO, Van Den Neste E, Dechene J, De Maertelaer V, Bron D, Englert Y. Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial. J Clin Oncol 2013;31:903-909.
11. Borroni R, Di Blasio AM, Gaffuri B, Santorsola R, Busacca M, Vigano P and Vignali M. Expression of GnRH receptor gene in human ectopic endometrial cells and inhibition of their proliferation by leuprolide acetate. Mol Cell Endocrinol 2000;159:37-43.
12. Imai A, Takagi A and Tamaya T. Gonadotropin-releasing hormone analog repairs reduced endometrial cell apoptosis in endometriosis in vitro. Am J Obstet Gynecol 2000;182:1142-1146.
13. Tang X, Yano T, Osuga Y, Matsumi H, Yano N, Xu J, Wada O, Koga K, Kugu K, Tsutsumi O, Schally AV, Taketani Y. Cellular mechanisms of growth inhibition of human epithelial ovarian cancer cell line by LH-releasing hormone antagonist Cetrorelix. J Clin Endocrinol Metab 2002;87:3721-3727.
14. Limonta P, Moretti RM, Marelli MM and Motta M. The biology of gonadotropin hormone-eleasing hormone:role in the control of tumor growth and progression in humans. Front Neuroendocrinol 2003;24:279-295.
15. Millar RP. GnRH-II and type-II GnRH receptors. Trends Endocrinol Metab 2003;14:35-43.
16. Siler-Khodr TM and Grayson M. Action of chicken II GnRH on the human placenta. J Clin Endocrinol Metab 2001;86:804-810.
17. Cheon KW, Lee HS, Parhar IS and Kang IS. Expression of the second isoform of gonadotrophin-releasing hormone (GnRH-II) in human endometrium throughout the menstrual cycle. Mol Hum Reprod 2001;7:447-452.
18. Choi KC, Auersperg N and Leung PC. Expression and antiproliferative effect of a second form of gonadotropin-releasing hormone in normal and neoplastic ovarian surface epithelial cells. J Clin Endocrinol Metab 2001;86:5075-5078.
19. Kang SK, Tai CJ, Nathwani PS and Leung PC. Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid in human granulosa-luteal cells. Endocrinology 2001;142:182-192.
20. Khosravi S and Leung PC. Differential regulation of gonadotropin-releasing hormone (GnRH)I and GnRH-II messenger ribonucleic acid by gonadal steroids in human granulosa luteal cells. J Clin Endocrinol Metab 2003;88:663-672.
21. Harrison GS, Wierman ME, Nett TM, Glode LM. Gonadotropin-releasing hormone and its receptor in normal and malignant cells. Endocr Relat Cancer 2004;11:725-748.
22. Enomoto M, Endo D, Kawashima S, Park MK. Human type-II GnRH receptor mediates effects of GnRH on cell proliferation. Zool Sci 2004;21:763-770.
23. Grundker C, Gunthert AR, Millar RP, Emons G. Expression of gonadotropin-releasing hormone-II (GnRH-II) receptor in human endometrial and ovarian cancer cells and effects of GnRH-II on tumor cell proliferation. J Clin Endocrinol Metab 2002;87:1427-1430.
24. Schubert A, Hawighorst T, Emons G, Gründker C. Agonists and antagonists of GnRH-I and -II reduce metastasis formation by triple-negative human breast cancer cells in vivo. Breast Cancer Res Treat 2011;130:783-790.
25. Morimoto C, Osuga Y, Yano T, Takemura Y, Harada M, Hirata T, Hirota Y, Yoshino O, Koga K, Kugu K, Taketani Y. GnRH-II as a possible cytostatic regulator in the development of endometriosis. Hum Reprod 2005;20:3212-3218.
26. Liu QH, Huang FY, Wang HP, Zou Y. GnRH-II in vitro culture of uterine in patients with endometriosis Endometrial stromal cells secrete VEGF influence. Journal of Central South University (Medical Edition) 2009;9:926-932.
27. Imai A, Sugiyama M, Furui T, Tamaya T. Treatment of perimenopausal women with uterine myoma:successful use of a depot GnRH agonist leading to a natural menopause. J Obstet Gynaecol 2003;23:518-520.
28. Huang FY, Wang HP, Liu QH, Zou Y. Effect of GnRHa on cell proliferation and VEGF's secreting of ectopic and eutopic stromal cells from patients with endometriosis in vitro. China Journal of Modern Medicine 2011;21:79-83, 86.
29. Kim KY, Choi KC, Park SH, Auersperg N, Leung PC. Extracellular signal-regulated protein kinase, but not c-Jun N-terminal kinase, is activated by type II gonadotropin-releasing hormone involved in the inhibition of ovarian cancer cell proliferation. J Clin Endocrinol Metab 2005;90:1670-1677.
30. Gründker C, Föst C, Fister S, Nolte N, Günthert AR, Emons G. Gonadotropin-releasing hormone type-II antagonist induces apoptosis in MCF-7 and triple-negative MDA-MB-231 human breast cancer cells in vitro and in vivo. Breast Cancer Res 2010;12:49-58.
31. Montagnani Marelli M, Moretti RM, Mai S, Januszkiewicz-Caulier J, Motta M, Limonta P. Type I gonadotropin-releasing hormone receptor mediates the antiproliferative effects of GnRH-II on prostate cancer cells. J Clin Endocrinol Metab 2009;94:1761-1767.
32. Chi XL, Zhou WX, Zhang YX, Chen JP. Type-II GnRH research progress and its receptor system. Proceedings of The Military Academy of Medical Sciences 2006;30:169-173.
33. Zou Y, Huang FY. Expression of GnRH-II protein in patient with endometriosis and its Significance. International Journal of Pathology and Clinical Medicine 2010;30:27-32.
34. Klemmt PA, Carver JG, Kennedy SH, Koninckx PR, Mardon HJ. The Stromal cells from endometriotic lesions and endometrium from women with endometriosis have reduced decidualization capacity. Fertil Steril 2006;30:564-572.
35. Han LW, Jiang WG. The effect of GnRHa on endometrial stromal cell proliferation and Angiogenesis in endometriosis. Progress in Obstetrics and Gynecology 2008;17:737-739.
36. Bilotas M, Baraño RI, Buquet R, Sueldo C, Tesone M, Meresman G. Effect of GnRH analogues on apoptosis and expression of Bcl-2, Bax, Fas and FasL proteins in endometrial epithelial cell cultures from patients with endometriosis and controls. Hum Reprod 2007;22:644-653.
37. Meresman GF, Bilotas MA, Lombardi E, Tesone M, Sueldo C, Barañao RI. Effect of GnRH analogues on apoptosis and release of interleukin-1beta and vascular endothelial growth factor in endometrial cell cultures from patients with endometriosis. Hum Reprod 2003;18:1767-1771.
38. Deng S, Lang JH, Leng JH, Liu ZF, Sun DW, Zhu L, Tan XJ. Effects of medical treatment on apoptosis in eutopic endometrium of patients with endometriosis. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2007;29:252-6.
39. Fister S, Günthert AR, Emons G, Gründker C. Gonadotropin-releasing hormone type-II antagonists induce apoptotic cell death in human endometrial and ovarian cancer cells in vitro and in vivo. Cancer Res 2007;67:1750-1756.
40. Zhao ZZ, Nyholt DR, Thomas S, Treloar SA, Montgomery GW. Polymorphisms in the vascular endothelial growth factor gene and the risk of familial endometriosis. Mol Hum Reprod 2008;14:531-538.
41. Gilabert-Estellés J, Ramón LA, España F, Gilabert J, Vila V, Réganon E, Castelló R, Chirivella M, Estellés A. Expression of angiogenic factors in endometriosis:relationship to fibrinolytic and metalloproteinase systems. Hum Reprod 2007;22:2120-2127.